⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 15 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 52 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 1 hour ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 15 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 52 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 1 hour ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT July 23, 2026

Valsartan Sandoz 320 mg - Filmtabletten 320 mg (Filmtablette)

📷 Wikipedia: Valsartan · Source
Valsartan Sandoz 320 mg - Filmtabletten 320 mg (Filmtablette)
📷 Wikipedia: Valsartan · Source

🚫 Parallel export ban active

ATC
C09CA03
Reason
Kapazitätsengpässe bei der Herstellung
Marketing authorisation holder
Sandoz GmbH, Biochemiestraße 10, 6250 Kundl, Österreich
Affected packs
28 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-07-23]
⚠️
Shortage ongoing
VALSARTAN is currently in short supply in AT.
📈 Timeline
4 days active so far
July 24, 2026 July 27, 2026
A plain-language summary will appear here shortly. Read the official notice below.
🔬 Medical / technical details (for professionals)
Active substance(s)
VALSARTAN
Agency-published detail

🚫 Parallel export ban active · ATC: C09CA03 · Reason: Kapazitätsengpässe bei der Herstellung · Marketing authorisation holder: Sandoz GmbH, Biochemiestraße 10, 6250 Kundl, Österreich · Affected packs: 28 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-07-23]

First published
July 23, 2026
Last refreshed by us
13 hours ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

High AT 5 days ago

Amlodipin/Valsartan/HCT 1A Pharma 5 mg/160 mg/12,5 mg - Filmtabletten 5/160/12,5 mg (Filmtablette)

Amlodipine/Valsartan/HCT 1A Pharma 5 mg/160 mg/12.5 mg film-coated tablets are unavailable due to manufacturing capacity issues.
High AT 2 weeks ago

Valsartan/HCT Sandoz 160 mg/12,5 mg - Filmtabletten 160 mg/12,5 mg (Filmtablette)

Valsartan/HCT Sandoz 160 mg/12.5 mg film-coated tablets are unavailable due to manufacturing capacity issues.
High AT 1 month ago

Valsartan/HCT 1A Pharma 160 mg/12,5 mg - Filmtabletten 160 mg/12,5 mg (Filmtablette)

Valsartan/HCT 1A Pharma 160 mg/12.5 mg film-coated tablets are unavailable due to manufacturing capacity issues.
High AT 1 month ago

Amlodipin/Valsartan/Hydrochlorothiazid ratiopharm 10 mg/320 mg/25 mg Filmtabletten 10/320/25 mg (Filmtablette)

Parallel export ban in effect. Supply delayed due to manufacturing issues. Affected packs: 30-count box, blister.
Medium AT 1 month ago

Amlodipin/Valsartan/HCT 1A Pharma 5 mg/160 mg/25 mg - Filmtabletten 5/160/25 mg (Filmtablette)

Amlodipine/Valsartan/HCT 1A Pharma 5 mg/160 mg/25 mg film-coated tablets are currently in limited supply due to manufacturing capacity issues.
High AT 1 month ago

Amlodipin/Valsartan/HCT Sandoz 10 mg/160 mg/25 mg – Filmtabletten 10/160/25 mg (Filmtablette)

Amlodipine/Valsartan/HCT Sandoz 10 mg/160 mg/25 mg film-coated tablets are unavailable due to manufacturing capacity issues.
Low AT resolved 1 month ago

Amlodipin/Valsartan Actavis 5 mg/80 mg Filmtabletten 5/80 mg/mg (Filmtablette)

Amlodipine/Valsartan Actavis 5 mg/80 mg film-coated tablets are delayed in production.
Medium AT resolved 2 months ago

Valsartan/HCT Sandoz 320 mg/25 mg - Filmtabletten 320 mg/25 mg (Filmtablette)

Valsartan/HCT Sandoz 320 mg/25 mg film tablets are subject to a parallel export ban due to manufacturing capacity shortages.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Valsartan Sandoz 320 mg - Filmtabletten 320 mg (Filmtablette). 🚫 Parallel export ban active · ATC: C09CA03 · Reason: Kapazitätsengpässe bei der Herstellung · Marketing authorisation holder: Sandoz GmbH, Biochemiestraße 10, 6250 Kundl, Österreich · Affected packs: 28 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-07-23]
▸ When was this alert issued?
This alert was issued on July 23, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.